ViaCell

company

About

ViaCell is a biotechnology company focused on the area of women’s health.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$48M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 1993
Number Of Employee
11 - 50
Operating Status
Active

ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs.

ViaCell is based in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$48M
ViaCell has raised a total of $48M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2000 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2000 Series Unknown $48M 3 Nomura International Detail

Investors

Number of Lead Investors
Number of Investors
1
3
ViaCell is funded by 3 investors. Nomura International and Sofinov Societe Financiere D'Innovation are the most recent investors.
Investor Name Lead Investor Funding Round
Nomura International Yes Series Unknown
Sofinov Societe Financiere D'Innovation Series Unknown
United Offshore Bank Venture Technology Investments Series Unknown